Treatments & Techniques
Clinical trials for disease-modifying therapy for Alzheimer’s disease are underway.
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.
New AMA Substance Use & Pain Care Task Force recommendations aim to improve opioid prescribing and addiction treatment.
Based on the Osteoporotic Fractures in Men Study, higher physical activity is associated with an increase in functional strength and mobility in older men, as well as decreased risk of hospitalization. Evidence suggests incorporating physical activity into primary care.
Vertebral body tethering (VBT), a surgical alternative to spinal fusion for patients with severe scoliosis, is not in widespread use, but research shows it could help certain populations, young athletes in particular. Still, there are drawbacks.
Recent trials and studies have led to promising insights and new options for the management and treatment of GERD for some patients.
Over the summer, the FDA approved Wegovy injections for chronic weight management, the first such drug approved since 2014. Manufactured by Novo Nordisk, the drug works by mimicking the hormone glucagon-like peptide-1 (GLP-1), which helps regulate...
Deep Brain Stimulation at Some Frequencies May Be as Effective as Medication for Parkinson’s Disease
A new study offers hope for improving DBS treatments.
For some patients with degenerative bone disorders, the human monoclonal antibody denosumab can reduce BMD loss and the risk for fractures. Ongoing research is revealing the advantages and risks.
- 1 of 27
- next ›